Stada Q1 Net Profit Down 35%

Stada Arzneimittel AG reported a drop in its earnings fell in the first quarter. Stada's quarterly net profit fell 35% y/y to EUR19.4 million, versus analysts' estimates of EUR25 million. Its sales gained 6% to EUR443.4 million, versus analysts' expectations of EUR455 million. Earnings before interest, taxes, depreciation, and amortization fell to EUR77.3 million, versus analysts' estimates of EUR86 million. Earnings per share declined 35% y/y to EUR0.33, versus analysts' estimates of EUR0.43.